Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease

CONTEXT: Guidelines recommend blood-based fibrosis biomarkers to identify advanced nonalcoholic fatty liver disease (NAFLD), which is particularly prevalent in patients with obesity. OBJECTIVE: To study whether the degree of obesity affects the performance of liver fibrosis biomarkers in NAFLD. DESI...

Descripción completa

Detalles Bibliográficos
Autores principales: Qadri, Sami, Ahlholm, Noora, Lønsmann, Ida, Pellegrini, Paola, Poikola, Anni, Luukkonen, Panu K, Porthan, Kimmo, Juuti, Anne, Sammalkorpi, Henna, Penttilä, Anne K, D’Ambrosio, Roberta, Soardo, Giorgio, Leeming, Diana J, Karsdal, Morten, Arola, Johanna, Kechagias, Stergios, Pelusi, Serena, Ekstedt, Mattias, Valenti, Luca, Hagström, Hannes, Yki-Järvinen, Hannele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016464/
https://www.ncbi.nlm.nih.gov/pubmed/34971370
http://dx.doi.org/10.1210/clinem/dgab933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016464/
https://www.ncbi.nlm.nih.gov/pubmed/34971370
http://dx.doi.org/10.1210/clinem/dgab933

Ejemplares similares